COMPARISON OF THE ACTIONS OF HYDROXYUREA AND 9-BETA-D-ARABINOFURANOSYL-2-FLUOROADENINE ON CYTOTOXICITY AND METABOLISM OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN HUMAN T-CELL LEUKEMIA-CELL LINE MOLT-3
Y. Shimono et al., COMPARISON OF THE ACTIONS OF HYDROXYUREA AND 9-BETA-D-ARABINOFURANOSYL-2-FLUOROADENINE ON CYTOTOXICITY AND METABOLISM OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN HUMAN T-CELL LEUKEMIA-CELL LINE MOLT-3, The Cancer journal, 11(5), 1998, pp. 247-253
Background - The combinations of 1-beta-D-arabinofuranosylcytosine (ar
a-C) and hydroxyurea (HU) or fludarabine arabinofuranosyl-2-fluoroaden
ine-5'-monophosphate, F-ara-AMP) have been introduced into clinical th
erapeutic regimens, because HU and F-ara-ATP inhibit RR activity and r
educe dNTP level, leading to a higher rate of dCK activity and a great
er accumulation of ara-CTP in cells. However, comparative studies of t
he biochemical modulation of HU and F-ara-A on ara-C metabolism have n
ot been precisely reported. Methods and Results - In-vitro median effe
ct analyses demonstrated that HU and ara-C showed synergistic drug int
eractions at concentrations more than 40 mu M of HU. con the other han
d, F-ara-A and ara-C showed a synergistic effect at less than 1 mu M F
-ara-A but additive or antagonistic effect at more than 1.5 mu M F-ara
-A. When compared at their respective IC(50)s and IC80s, HU produced h
igher intracellular ara-CTP than F-ara-A. Incorporation of radioactive
ara-C or F-ara-A into cells was partially inhibited by unlabeled F-ar
a-A or ara-C, respectively. Measurement of DNA polymerase activities b
y the permeabilized cell method showed an additive inhibitory effect o
f ara-CTP and F-ara-ATP on DNA polymerase activity under these experim
ental conditions. HU and the lowest concentration of F-ara-A (3 mu M)
mainly inhibited RR activity. However, higher concentrations of F-ara-
A (7 and 10 mu M) showed bifunctional inhibitory effects on RR activit
y and DNA synthesis, Conclusions - F-ara-A acts on the metabolism, of
nucleic acids in different way depending on its concentration. This du
al action of F-ara-A on RR activity and DNA synthesis should be taken
into accounts when F-ara-A is used in combination with ara-C in a clin
ical setting.